COM:ALPHACOGNITION
Alpha Cognition Inc.
- Stock
market
STOCKSindustry
Biopharmaceuticalswebsite
alphacognition.comcrunchbase
neurodyn-cognitionlinkedin
alpha-cognition-incfounding date
Jan 01, 2014ipo date
Jun 28, 2021
Alpha Cognition Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; and ALPHA-0602, a gene therapy for the treatment of ALS. The company ...Show More